CLINICAL_TRIALS
trial_result
· 2024-09-19
Clinical Trial Update: Memesto Wearable Repetitive Message and Music Therapy Device Music Therapy Device That Senses and Reduces Agitation in People With AD, [NA]
Summary
The study of the Memesto wearable device for reducing agitation in Alzheimer's disease has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Edgewater Safety Systems, Inc. | Conditions: Alzheimer's Disease | NA | Status: COMPLETED